Aldeyra Therapeutics, Inc. - Common Stock (ALDX)
5.2400
-0.1600 (-2.96%)
Aldeyra Therapeutics is a biotechnology company focused on developing and commercializing innovative therapies to treat immune-mediated and metabolic diseases
The company is particularly known for its research in ocular disorders and rare diseases, utilizing its proprietary platform to create novel compounds that aim to modulate immune responses and address unmet medical needs. Aldeyra is committed to advancing its therapeutic pipeline through clinical trials, bringing potential new treatment options to patients facing debilitating health conditions.
Frequently Asked Questions
Is Aldeyra Therapeutics, Inc. - Common Stock publicly traded?
Yes, Aldeyra Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Aldeyra Therapeutics, Inc. - Common Stock trade on?
Aldeyra Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aldeyra Therapeutics, Inc. - Common Stock?
The ticker symbol for Aldeyra Therapeutics, Inc. - Common Stock is ALDX on the Nasdaq Stock Market
What is the current price of Aldeyra Therapeutics, Inc. - Common Stock?
The current price of Aldeyra Therapeutics, Inc. - Common Stock is 5.240
When was Aldeyra Therapeutics, Inc. - Common Stock last traded?
The last trade of Aldeyra Therapeutics, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Aldeyra Therapeutics, Inc. - Common Stock?
The market capitalization of Aldeyra Therapeutics, Inc. - Common Stock is 306.94M
How many shares of Aldeyra Therapeutics, Inc. - Common Stock are outstanding?
Aldeyra Therapeutics, Inc. - Common Stock has 58.58M shares outstanding.